Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5266924
Max Phase: Preclinical
Molecular Formula: C30H41BrN6O2
Molecular Weight: 597.60
Associated Items:
ID: ALA5266924
Max Phase: Preclinical
Molecular Formula: C30H41BrN6O2
Molecular Weight: 597.60
Associated Items:
Canonical SMILES: C/C(=C/CN1CN(C)c2ncnc(N)c21)C[C@]1(C)[C@@H](C)CC[C@@]2(C)C(COC(=O)c3cc(Br)c[nH]3)=CCC[C@@H]12
Standard InChI: InChI=1S/C30H41BrN6O2/c1-19(10-12-37-18-36(5)27-25(37)26(32)34-17-35-27)14-30(4)20(2)9-11-29(3)21(7-6-8-24(29)30)16-39-28(38)23-13-22(31)15-33-23/h7,10,13,15,17,20,24,33H,6,8-9,11-12,14,16,18H2,1-5H3,(H2,32,34,35)/b19-10-/t20-,24+,29-,30+/m0/s1
Standard InChI Key: ALFLIPUMBAFPLH-DUNRNJJLSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 597.60 | Molecular Weight (Monoisotopic): 596.2474 | AlogP: 6.34 | #Rotatable Bonds: 7 |
Polar Surface Area: 100.37 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 8 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 11.23 | CX Basic pKa: 7.30 | CX LogP: 6.72 | CX LogD: 6.47 |
Aromatic Rings: 2 | Heavy Atoms: 39 | QED Weighted: 0.28 | Np Likeness Score: 1.35 |
1. Mahamed S, Motal R, Govender T, Dlamini N, Khuboni K, Hadeb Z, Shaik BB, Moodley K, Balaso Mohite S, Karpoormath R.. (2023) A concise review on marine bromopyrrole alkaloids as anticancer agents., 80 [PMID:36496202] [10.1016/j.bmcl.2022.129102] |
Source(1):